CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Noncontrolling Interest [Member]	Total
Balance at Sep. 30, 2018	$ 753	$ 249,119,833	$ (248,366,083)		$ 754,503
Balance (in shares) at Sep. 30, 2018	752,802
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in public offering, net of offering costs	$ 137	2,262,234			2,262,371
Common stock issued in public offering, net of offering costs (in shares)	137,500
Impact of adoption of new accounting pronouncements included in accumulated deficit			493,223		493,223
Stock based compensation expense		490,244			490,244
Net loss			(3,234,320)		(3,234,320)
Balance at Dec. 31, 2018	$ 890	251,872,311	(251,107,180)		766,021
Balance (in shares) at Dec. 31, 2018	890,302
Balance at Sep. 30, 2019	$ 1,200	255,962,930	(256,805,589)	$ (7,040)	$ (848,499)
Balance (in shares) at Sep. 30, 2019	1,200,399				1,200,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in public offering, net of offering costs	$ 2,285	10,527,745			$ 10,530,030
Common stock issued in public offering, net of offering costs (in shares)	2,285,000
Deemed dividend - warrant repricing		2,842	(2,842)
Stock based compensation expense		205,490			205,490
Net loss			(2,662,711)	(30)	(2,662,741)
Balance at Dec. 31, 2019	$ 3,485	$ 266,699,007	$ (259,471,142)	$ (7,070)	$ 7,224,280
Balance (in shares) at Dec. 31, 2019	3,485,399				3,485,399